DK123823B - Fremgangsmåde til fremstilling af 2-thiopyrimidin- eller 2-thio-6-azapyrimidinnucleosider. - Google Patents

Fremgangsmåde til fremstilling af 2-thiopyrimidin- eller 2-thio-6-azapyrimidinnucleosider.

Info

Publication number
DK123823B
DK123823B DK495969AA DK495969A DK123823B DK 123823 B DK123823 B DK 123823B DK 495969A A DK495969A A DK 495969AA DK 495969 A DK495969 A DK 495969A DK 123823 B DK123823 B DK 123823B
Authority
DK
Denmark
Prior art keywords
thiopyrimidine
thio
preparation
azapyrimidine
nucleosides
Prior art date
Application number
DK495969AA
Other languages
Danish (da)
English (en)
Inventor
P Strehlke
H Vorbrueggen
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK123823B publication Critical patent/DK123823B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0898—Compounds with a Si-S linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/12—Triazine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK495969AA 1968-09-18 1969-09-17 Fremgangsmåde til fremstilling af 2-thiopyrimidin- eller 2-thio-6-azapyrimidinnucleosider. DK123823B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681795357 DE1795357A1 (de) 1968-09-18 1968-09-18 2-Thio-pyrimidin-nucleoside

Publications (1)

Publication Number Publication Date
DK123823B true DK123823B (da) 1972-08-07

Family

ID=5708152

Family Applications (1)

Application Number Title Priority Date Filing Date
DK495969AA DK123823B (da) 1968-09-18 1969-09-17 Fremgangsmåde til fremstilling af 2-thiopyrimidin- eller 2-thio-6-azapyrimidinnucleosider.

Country Status (18)

Country Link
US (1) US3708469A (OSRAM)
JP (1) JPS5250795B1 (OSRAM)
AT (1) AT311560B (OSRAM)
BE (1) BE739035A (OSRAM)
BR (1) BR6912517D0 (OSRAM)
CA (1) CA930732A (OSRAM)
CH (1) CH523893A (OSRAM)
DE (1) DE1795357A1 (OSRAM)
DK (1) DK123823B (OSRAM)
ES (1) ES371463A1 (OSRAM)
FR (1) FR2018355B1 (OSRAM)
GB (1) GB1286854A (OSRAM)
IE (1) IE33314B1 (OSRAM)
NL (1) NL6914196A (OSRAM)
PH (1) PH9966A (OSRAM)
PL (1) PL80196B1 (OSRAM)
RO (1) RO54466A (OSRAM)
SE (1) SE364513B (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU452961A3 (ru) * 1969-04-11 1974-12-05 Шеринг Аг. (Фирма) Способ получени пиримидиннуклеозидов
DE2032424A1 (de) * 1970-06-23 1972-01-20 Schering AG, Berlin und Bergkamen, 1000 Berlin 2 Thio 5 aza cytosin und dessen Nucleoside
FR2066931A2 (en) * 1970-10-30 1971-08-13 Schering Ag 2-thio -6-aza-uridine derivs
GB1376437A (en) * 1970-12-21 1974-12-04 Upjohn Co Nucleoside derivatives and the preparation thereof
US3975374A (en) * 1970-12-21 1976-08-17 The Upjohn Company Process for preparing 2-thiouracil nucleosides
DE2122991C2 (de) * 1971-05-04 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von Cytosin- und 6-Azacytosinnucleosiden
US4090021A (en) * 1971-10-08 1978-05-16 Schering Aktiengesellschaft Process for the production of N6 -substituted adenosine nucleotides and products resulting therefrom
US3919193A (en) * 1973-07-06 1975-11-11 Icn Pharmaceuticals 3-Deazaguanosine and derivatives thereof
US4171431A (en) * 1976-08-19 1979-10-16 The Upjohn Company Nucleosides and process
DE2721466A1 (de) * 1977-05-12 1978-11-16 Robugen Gmbh Verfahren zur herstellung von 2'-desoxyribofuranosylnucleosiden
DE2757365A1 (de) * 1977-12-20 1979-06-21 Schering Ag Neues verfahren zur herstellung von nucleosiden
US4423212A (en) * 1980-12-18 1983-12-27 The Upjohn Company Nucleosides and process
US4760137A (en) * 1984-08-06 1988-07-26 Brigham Young University Method for the production of 2'-deoxyadenosine compounds
CA1269659A (en) * 1984-08-06 1990-05-29 Brigham Young University Method for the production of 2'-deoxyadenosine compounds

Also Published As

Publication number Publication date
CA930732A (en) 1973-07-24
AT311560B (de) 1973-11-26
GB1286854A (en) 1972-08-23
RO54466A (OSRAM) 1973-05-17
PH9966A (en) 1976-06-16
US3708469A (en) 1973-01-02
ES371463A1 (es) 1971-10-16
JPS5250795B1 (OSRAM) 1977-12-27
NL6914196A (OSRAM) 1970-03-20
SE364513B (OSRAM) 1974-02-25
CH523893A (de) 1972-06-15
PL80196B1 (OSRAM) 1975-08-30
DE1795357A1 (de) 1972-01-05
SU399133A3 (OSRAM) 1973-09-27
FR2018355B1 (OSRAM) 1974-02-22
IE33314B1 (en) 1974-05-15
FR2018355A1 (OSRAM) 1970-05-29
BE739035A (OSRAM) 1970-03-18
BR6912517D0 (pt) 1973-05-10
IE33314L (en) 1970-03-18

Similar Documents

Publication Publication Date Title
DK127923B (da) Fremgangsmåde til fremstilling af maltitol.
DK126193B (da) Analogifremgangsmåde til fremstilling af derivater af substitueret N-amino-indolin.
DK126198B (da) Fremgangsmåde til fremstilling af pyrimidinnucleosider eller 6-azapyrimidinnucleosider.
DK122964B (da) Fremgangsmåde til fremstilling af 3-amino-4-iod-5-methylisoxazolderivater.
DK137498B (da) Analogifremgangsmåde til fremstilling af triazolpyrimidinderivater.
DK119765B (da) Fremgangsmåde til fremstilling af digitoxigeninglycosider.
DK123715B (da) Fremgangsmåde til fremstilling af 4'-demethylepipodophyllotoxin-β-D-alkylidenglucosider.
DK129656B (da) Analogifremgangsmåde til fremstilling af derivater af S-triazin.
DK125091B (da) Fremgangsmåde til fremstilling af 1-hydroxy-2-pyridoner.
DK125852B (da) Fremgangsmåde til fremstilling af erythromycylamin.
DK122124B (da) Fremgangsmåde til fremstilling af 2-acyloxythionobenzamider.
DK133430B (da) Analogifremgangsmåde til fremstilling af 1-carbamoyl-3-aroylpyrrolidiner.
DK119304B (da) Fremgangsmåde til fremstilling af D-ribose.
DK123300B (da) Analogifremgangsmåde til fremstilling af thiophen-3-isonitriler.
DK131863B (da) Analogifremgangsmåde til fremstilling af thiazolino- eller thiazidino-pyrimidinderivater.
DK128540B (da) Analogifremgangsmåde til fremstilling af pyrazolodiazepinonforbindelser.
DK128008B (da) Fremgangsmåde til fremstilling af 1-glykosyl-5-azacytosiner.
DK120292B (da) Analogifremgangsmåde til fremstilling af 2-aryloksymetylpiperazinderivater.
DK122132B (da) Analogifremgangsmåde til fremstilling af [(fenylamino)-pyridyl-3]-5-tetrazoler.
DK140726B (da) Fremgangsmåde til fremstilling af delta2-cephalosporin-forbindelser.
DK123479B (da) Fremgangsmåde til fremstilling af chromanoler.
DK121084B (da) Fremgangsmåde til fremstilling af benzomorphanderivater.
DK122816B (da) Analogifremgangsmåde til fremstilling af 3-aryl-5-methylhydantoiner.
DK127554B (da) Analogifremgangsmåde til fremstilling af 14α 17α-methylendioxy-19-nor-progesteronderivater.
DK127107B (da) Fremgangsmåde til fremstilling af 17α-propadienyl-17β-hydroxy-steroider.